These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 17617589)

  • 1. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.
    Sinha P; Clements VK; Bunt SK; Albelda SM; Ostrand-Rosenberg S
    J Immunol; 2007 Jul; 179(2):977-83. PubMed ID: 17617589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4.
    Bunt SK; Clements VK; Hanson EM; Sinha P; Ostrand-Rosenberg S
    J Leukoc Biol; 2009 Jun; 85(6):996-1004. PubMed ID: 19261929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.
    Sinha P; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2013 Nov; 62(11):1663-73. PubMed ID: 23982485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors.
    Beury DW; Parker KH; Nyandjo M; Sinha P; Carter KA; Ostrand-Rosenberg S
    J Leukoc Biol; 2014 Dec; 96(6):1109-18. PubMed ID: 25170116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    J Immunol; 2005 Jan; 174(2):636-45. PubMed ID: 15634881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.
    Younis RH; Han KL; Webb TJ
    J Immunol; 2016 Feb; 196(3):1419-29. PubMed ID: 26740106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα.
    Sinha P; Parker KH; Horn L; Ostrand-Rosenberg S
    Eur J Immunol; 2012 Aug; 42(8):2052-9. PubMed ID: 22673957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2.
    Beury DW; Carter KA; Nelson C; Sinha P; Hanson E; Nyandjo M; Fitzgerald PJ; Majeed A; Wali N; Ostrand-Rosenberg S
    J Immunol; 2016 Apr; 196(8):3470-8. PubMed ID: 26936880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
    Sinha P; Okoro C; Foell D; Freeze HH; Ostrand-Rosenberg S; Srikrishna G
    J Immunol; 2008 Oct; 181(7):4666-75. PubMed ID: 18802069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer.
    Dufait I; Schwarze JK; Liechtenstein T; Leonard W; Jiang H; Escors D; De Ridder M; Breckpot K
    Oncotarget; 2015 May; 6(14):12369-82. PubMed ID: 25869209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.
    Bunt SK; Yang L; Sinha P; Clements VK; Leips J; Ostrand-Rosenberg S
    Cancer Res; 2007 Oct; 67(20):10019-26. PubMed ID: 17942936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
    Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
    J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
    Li H; Han Y; Guo Q; Zhang M; Cao X
    J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression.
    Sinha P; Clements VK; Miller S; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2005 Nov; 54(11):1137-42. PubMed ID: 15877228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
    Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
    Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
    Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
    J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
    Sinha P; Clements VK; Fulton AM; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4507-13. PubMed ID: 17483367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.